Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC

Detalles Bibliográficos
Autores principales: Malapelle, Umberto, Tabbò, Fabrizio, Muscarella, Lucia Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325716/
https://www.ncbi.nlm.nih.gov/pubmed/37427122
http://dx.doi.org/10.3389/fonc.2023.1239304
_version_ 1785069280431177728
author Malapelle, Umberto
Tabbò, Fabrizio
Muscarella, Lucia Anna
author_facet Malapelle, Umberto
Tabbò, Fabrizio
Muscarella, Lucia Anna
author_sort Malapelle, Umberto
collection PubMed
description
format Online
Article
Text
id pubmed-10325716
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103257162023-07-07 Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC Malapelle, Umberto Tabbò, Fabrizio Muscarella, Lucia Anna Front Oncol Oncology Frontiers Media S.A. 2023-06-22 /pmc/articles/PMC10325716/ /pubmed/37427122 http://dx.doi.org/10.3389/fonc.2023.1239304 Text en Copyright © 2023 Malapelle, Tabbò and Muscarella https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Malapelle, Umberto
Tabbò, Fabrizio
Muscarella, Lucia Anna
Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title_full Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title_fullStr Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title_full_unstemmed Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title_short Editorial: Concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in NSCLC
title_sort editorial: concomitant pathogenic mutations in oncogene-driven subgroups: when next generation biology meets targeted therapy in nsclc
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325716/
https://www.ncbi.nlm.nih.gov/pubmed/37427122
http://dx.doi.org/10.3389/fonc.2023.1239304
work_keys_str_mv AT malapelleumberto editorialconcomitantpathogenicmutationsinoncogenedrivensubgroupswhennextgenerationbiologymeetstargetedtherapyinnsclc
AT tabbofabrizio editorialconcomitantpathogenicmutationsinoncogenedrivensubgroupswhennextgenerationbiologymeetstargetedtherapyinnsclc
AT muscarellaluciaanna editorialconcomitantpathogenicmutationsinoncogenedrivensubgroupswhennextgenerationbiologymeetstargetedtherapyinnsclc

Ejemplares similares